NASDAQ:ALBT - Nasdaq - US05344R3021 - Common Stock - Currency: USD
NASDAQ:ALBT (5/23/2025, 5:06:40 PM)
3.77
-0.07 (-1.82%)
The current stock price of ALBT is 3.77 USD. In the past month the price increased by 4.85%. In the past year, price decreased by -15.03%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LB | LANDBRIDGE CO LLC-A | 86.18 | 6.00B | ||
VTMX | CORP INMOBILIARIA VESTA-ADR | 8.65 | 2.47B | ||
IRS | IRSA -SP ADR | N/A | 1.13B | ||
KW | KENNEDY-WILSON HOLDINGS INC | N/A | 839.42M | ||
MRNO | MURANO GLOBAL INVESTMENTS PL | N/A | 799.53M | ||
FRPH | FRP HOLDINGS INC | 77.85 | 505.31M | ||
MLP | MAUI LAND & PINEAPPLE CO | N/A | 308.14M | ||
TCI | TRANSCONTINENTAL REALTY INV | 49.18 | 288.92M | ||
LPA | LOGISTIC PROPERTIES OF THE A | N/A | 263.08M | ||
OZ | BELPOINTE PREP LLC | N/A | 246.95M | ||
SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 230.07M | ||
RITR | REITAR LOGTECH HOLDINGS LTD | 39.89 | 224.16M |
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The firm is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
AVALON GLOBOCARE CORP
4400 Route 9, Suite 3100
Freehold NEW JERSEY US
Employees: 5
Phone: 17327804400
The current stock price of ALBT is 3.77 USD. The price decreased by -1.82% in the last trading session.
The exchange symbol of AVALON GLOBOCARE CORP is ALBT and it is listed on the Nasdaq exchange.
ALBT stock is listed on the Nasdaq exchange.
AVALON GLOBOCARE CORP (ALBT) has a market capitalization of 6.22M USD. This makes ALBT a Nano Cap stock.
AVALON GLOBOCARE CORP (ALBT) currently has 5 employees.
AVALON GLOBOCARE CORP (ALBT) has a support level at 3.62 and a resistance level at 3.78. Check the full technical report for a detailed analysis of ALBT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALBT does not pay a dividend.
AVALON GLOBOCARE CORP (ALBT) will report earnings on 2025-05-26.
AVALON GLOBOCARE CORP (ALBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.56).
The outstanding short interest for AVALON GLOBOCARE CORP (ALBT) is 5.47% of its float. Check the ownership tab for more information on the ALBT short interest.
ChartMill assigns a technical rating of 1 / 10 to ALBT. When comparing the yearly performance of all stocks, ALBT is a bad performer in the overall market: 81.93% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to ALBT. ALBT may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALBT reported a non-GAAP Earnings per Share(EPS) of -8.56. The EPS increased by 37.49% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -37.66% | ||
ROE | -111.27% | ||
Debt/Equity | 0.3 |